|
|
 |
|
|
 |
Precision Diagnostics
 |
Although
science is always ahead of practice in the medical field, the gap
today in the area of personalized medicine is inexcusably large …. ”
|
|
|
Realizing the Promise of
Personalized Medicine
Harvard Business Review
October 2007
|
|
|
Why do we have to wait until we’re in Intensive Care to get the benefits of
today’s science – leading-edge drugs, advanced surgical techniques and more?
Why can’t we use precision screening and diagnostic tools to keep us well and
out of Intensive Care?
A landmark study - Preventive Health Examinations and Preventive Gynecological
Examinations in the United States - published in the Archives of
Internal Medicine in September, 2007 found that there’s “real unclear
benefit” from standard annual “check-ups”. Reasons – they still
rely on outmoded screening techniques and seldom produce any change
in our behavior.
Scienta Health set out to revolutionize the way we think about health and annual screening.
Our integrated diagnostic protocols apply the very latest science has to
offer to pinpoint your unique risk profile and to accurately diagnose any
emerging health problems, often before you notice the symptoms. Click on the relevant disease category below for more information.

Cardiovascular Risk
A shocking number of heart attacks could be prevented. Resulting death rates may have declined recently, but it’s only because expensive life-saving surgical procedures have advanced so dramatically.
Why even take the risk?
The well-known, but increasingly challenged Framingham Study reported a direct correlation between high LDL cholesterol and statistical risk of a heart attack. Nevertheless, a frightening number of heart attacks continue to occur in individuals whose cholesterol measures “normal”. Indeed, the American Heart Association reports that 50% of men and 64% of women dying suddenly of coronary heart disease had no prior symptoms!
Research now shows cholesterol tests (measuring total cholesterol, LDL, HDL, and triglycerides) to be dangerously misleading - they identify only 40% of those at risk. Yet, these tests remain the primary means for healthcare professionals to assess risk of heart disease. Only very recently has it been acknowledged in a major study that an inflammation marker (highly-sensitive C-Reactive Protein) is actually more predictive – something we have asserted for years.
Development of heart disease involves multiple risk factors. For certain individuals, high LDL cholesterol may be one factor. Inflammatory protein levels, predisposition to clotting and other genetic factors all play a role. Diagnostic tests, such as the treadmill Stress Test, usually only register positive when arterial blockage reaches 85-90% - requiring crisis-style intervention.
Heart disease lurks silently within - hidden and unsuspected. Don’t wait for surgery to correct problems – you might not make it that far. Take preventive action.
Now, a number of advanced diagnostic tests and imaging techniques help identify individuals at risk and enable us to more accurately target the most appropriate interventions. Enhanced information means more effective treatment and vastly improved health outcomes:
Testing:
- LDL and HDL Fingerprinting
- Cholesterol Drug Selection Assessment
- CT Calcium Scoring and CT Angiography
- Plaque Stability Test
- Risk of Congestive Heart Failure
|
|
Cancer Risk
Cancer continues to be one of the most deadly types of disease in modern society. Triggers causing development of cancer - uncontrolled growth of abnormal cells – are numerous and complex. Genetics, along with environmental factors - stress, poor nutrition or lifestyle, exposure to toxins - play a large role.
The Scienta Health Team recommends everyone adopt a preventive approach - beginning with lifestyle and nutrition. Unfortunately, many facets of lifestyles fall outside of reasonable control. Examples - frequent long-distance air travel (exposure to cosmic radiation), pollutants in the air, toxins in food and even potential radiation from electronic equipment (microwave, cell-phone). Along with awareness and reasonable avoidance of these risks, we advocate risk identification and regular screening for very early detection.
Cancer risk assessment techniques include identification of genetic predisposition, using DNA and RNA technology. Early detection methods include unique biochemical markers (identifying very early onset at a cellular level, often before most imaging technologies allow us to “see” tumors) and prudent use of more advanced imaging such as MRI.
The goal at all times is utmost vigilance – knowing risks, screening regularly. Next to prevention, early detection is essential. Common statistics for various cancers reinforce this: detected in Stage 1-2 (early onset), treatment produces a 5-year survival rate of 85-90%; in Stage 4 (progressive disease), 5 year survival rates can be as low as 5-10%.
Diagnostic screening techniques continue to develop at a rapid pace. We at Scienta Health are constantly scanning the globe for the best.
Testing:
- Baseline Cancer Screen (general & specific blood markers)
- Specific Cancer Screening:
- Colorectal
- Lung
- Bladder
- Breast
- Prostate
|
MRI Spectroscopy non-invasively shows malignant tumor
|
Colorectal Cancer
Colon cancer persists as a major killer disease. Traditional screening has serious shortcomings:
The stool blood test - an “ancient” practice that should have no place in medicine today - fails to detect serious tumors and produces misleading false positives.
The colonoscopy has an important function in that it allows simultaneous live intervention if required. But, it has shortcomings and disadvantages - it requires unpleasant, disruptive preparation; it involves risk of rupturing of the colon; unless performed by an experienced GI specialist, it can “miss” the most malignant “flat” tumors and, when considering the typical recommended frequency (every 3 to 5 years), it leaves you vulnerable to developing problems in the intervening time.
Scienta Health is among the first in North America and the first in Canada to offer unique Colon Cancer detection tests:
Testing:
- DNA-based Stool Test
- RNA-based Blood Test
- Virtual (CT) Colonoscopy
Lung Cancer
Typically, even today, diagnosis of this terrible disease is limited to Chest X-ray or CT scanning, both emitting radiation. Moreover, screening commonly only occurs when symptoms of the disease begin – blood in the sputum. At this point, if cancer is present, it will have advanced significantly.
Clearly, there is a serious need for earlier detection.
Testing:
- Cytology-based Sputum Test
Bladder Cancer
Important facts, especially for men:
- Bladder cancer is almost three times more common among men than women
- Incidence in men is almost as high as that of colon cancer.
- When detected and treated early chances for survival are very good.
- But … recurrence rates are 50 to 80%, hence importance of very close and regular monitoring.
What causes bladder cancer?
- Smoking - the greatest risk factor. The American Cancer Society reports smokers and ex-smokers face double the risk rate of non-smokers. Risk among ex-smokers remains very high since cells lining bladder walls turn over very slowly, allowing abnormal cells to establish themselves.
- Occupations with certain environmental exposure - fire fighters, fire investigators, coalminers, truck drivers and those who work with textiles, rubber, petrochemicals and dyes.
Testing:
Breast Cancer
The # 2 cause of death from cancer among women (after lung cancer), this disease can strike early or later in a woman’s life.
The most common screening tool, the mammogram, is awkward and unreliable. Digital mammography has improved accuracy, as has combination of digital mammography with ultrasound. Nevertheless, these combined techniques often miss cancers, particularly among women with dense (little fatty tissue) or large breasts.
Women with the BRCA breast cancer genes are significantly more sensitive to adverse effects of radiation involved in mammography – repeated mammograms further increase their already high cancer risk.
Testing:
- MRI (Magnetic Resonance Imaging) of the Breast
Prostate Cancer
The # 3 cause of death from cancer among men (after lung and colon cancer), all men are at risk. If detected early one has several options for cure. Once the cancer has advanced and, or if it’s in certain aggressive forms, cure is less likely.
Traditional screening involves measurement of the blood enzyme PSA. Few realize this test is only 35% specific for prostate cancer – it can fail to detect presence of cancer in 65% of instances! This is totally inadequate.
Ultrasound can detect nodules in the prostate, but differentiation between benign and cancerous lesions requires a biopsy.
Testing:
- MRI (Magnetic Resonance Imaging) of the Prostate
Diabetes Risk
A 21st century scourge – once diagnosed, diabetes requires intense focus on diet, constant monitoring of insulin and, in many cases, careful, precise dosing. Most North Americans are aware of this; few really appreciate the life-changing impact.
Worse, even fewer are aware of the multitude of serious complications and related health risks caused by diabetes. These include much higher probability of cardiovascular disease, cancer and also organ damage that leads to blindness and kidney failure.
- Type 1 diabetes - usually diagnosed in children and adolescents, occurs when the pancreas is unable to produce insulin. Accounting for 10% of diabetes cases, life expectancy for Type 1 diabetics may be shortened by as much as 15 years.
- Type 2 diabetes - when the pancreas produces insufficient insulin or when the body cannot effectively use insulin (insulin resistance due to obesity). Type 2 usually develops in adulthood, although increasing numbers of children in high-risk populations are being diagnosed. Life expectancy for Type 2 diabetics may be shortened by 5 to 10 years.
A shocking number of individuals are Type 2 diabetic but unaware of it, simply because they do not have regular health check-ups. Even if they do, the typical health check-up includes a test of blood glucose levels (6 to 7 mmol/L is regarded as “pre-diabetic”. 7 or over is defined as diabetic). But, this is a “lagging indicator” - it tells you after the fact.
How can you find out if you’re heading in the wrong direction? First, we now have access to testing that provides predictive markers (see below). Second, anyone with metabolic syndrome should know that they face a 25% increased risk of Type 2 diabetes, as well as heart disease and other diseases.
Metabolic Syndrome is defined by several conditions:
- Abnormal blood sugar - insulin resistance
- Clotting state (e.g. high fibrinogen or plasminogen activator inhibitor-1 in the blood)
- Inflammatory state (e.g., elevated C-reactive protein in the blood)
- High LDL (“bad”) cholesterol and triglycerides and low HDL (“good”) cholesterol
- High blood pressure (higher than140/90)
- Abdominal obesity (men >40”/102 cm; women >35”/88 cm)
|
|
Testing:
- Insulin Resistance Breath Test
Genetic analysis involves much more than predicting disease. It’s the key to true Personalized Medicine – much more precise risk identification, disease detection and treatment, especially in prescription of medications.
Gone are the days of “one size fits all” (population-based medicine), because we know emphatically – one size does NOT fit all. We are each unique. Soon, too, we will see the end of “trial and error” medicine – the need to experiment with prescription and dosage of powerful medications. Pharmacogenetic analysis already enables precise prescribing.
A sputum sample or a cheek swab tests for presence or absence of genes that identify susceptibility or resistance to specific diseases, reaction to medications, ability to process nutrients and vulnerability to environmental factors.
These insights enable earlier intervention and accurate treatment. One’s genetic predisposition may be a given, but the way in which genes express themselves can be altered - through nutrition, lifestyle modification and medication - to reduce risk, prevent disease and attain greater health.
Application of genetic analysis in everyday healthcare is in its infancy, yet the insights gained by integrating this potent information into overall health screening have already been dramatic.
Scienta Health has been a globally recognized pioneer in this regard. We partner very closely with leading labs in the US and Europe.
Testing:
- General Preventive Genetic Profiling
By scanning the DNA for risk markers associated with predisposition to common and uncommon health conditions, this test provides knowledge that enables our team to focus on uniquely personalized disease prevention initiatives. Health risks covered include cardiovascular diseases, cancer, diabetes, gastrointestinal conditions, arthritis and eye diseases.
- Cardiac Risk Profiling
Genetic markers for which this scan probes include predisposition to atherosclerosis, hypertension, coronary artery disease and stroke, disorders in cholesterol regulation and metabolism, clotting conditions, and risk of free-radical formation.
- Metabolic Syndrome Risk Profiling
Here we look for common genetic variants that determine obesity, insulin resistance, type 2 diabetes, high blood pressure, inflammation and abnormalities in lipoprotein and glucose metabolism.
- Pharmacogenetic Profiling
Genetic variations give rise to differing response to drugs based on each individual’s ability to effectively metabolize the ingredients, allowing prescription and drug dosage with targeted precision and reducing risk of toxicity and unwanted side effects.
Nutrition & Toxicity
Nutrient deficiencies are a major contributor to disease risk. Insights are gained into the quality of your diet, possible issues of nutrient absorption and excessive exposure to toxins through the measurement of key nutrient levels and toxic elements.
Testing:
- Nutrient & Toxicity Metabolomics
Function:
This unique diagnostic profile provides an overview of your total nutritional status. By measuring 39 key organic acids and 38 amino acids, we can evaluate gastrointestinal function, cellular energy production, neurotransmitter processing, and functional need for vitamins, minerals and co-factors.
|
|
Understanding the degree of functional need for vitamins and minerals will assist in determining if dietary changes alone or additional personalized recommendations for vitamin, mineral and other nutrient supplementation are required to optimize these critical nutrient levels to maintain excellent metabolic health.
- anti-oxidants – involved in tissues repair and immunity
- B vitamins – critical in nerve and brain function, blood cell production
- minerals - co-factor in many enzyme reactions of metabolism
- fatty acids – affects cellular communication and regulates inflammation
- amino acids – building blocks for proteins – for tissue and hormone production
Testing Procedure: Simple fasting blood test
Your diet may be healthy but, does your body have the necessary nutrients to sustain optimal health?
And, are you harboring toxins such as lead, mercury and more, that drain energy and contribute to cancer?
Balanced nutrient levels and absence of toxins are critical to your ability to prevent illness and inflammation, to fight off infection and to repair tissue.
Allergens & Antibodies
|
‘Allergies’ that result in acute adverse reactions to certain foods or inhalants are increasingly common in our urban environments. More insidious, because the effects are subtle but deep-seated, are the “immune” responses we might experience.
|
|
Some acute reactions to allergies are seriously debilitating, even if temporary, while others can even be fatal. We need to be aware of them and take the right measures to avoid and mitigate.
The more subtle ‘immune’ responses caused by presence of antibodies range from simple “silent rejection” of or inability to absorb nutrients, to chronic symptoms such as headaches, sinus congestion, bloating, irritable bowel, fatigue and unexplained weight gain.
Testing:
- Food and Inhalant Antibodies (IgE & IgG)
|
 |
 |
|